Billionaire Profile
Willy Michel
Global Rank
#1010

Image: Harvey Kneeslapper | CC0 | via Wikimedia Commons

Willy Michel

CEO, Medical devices
SWITZERLAND
Real-Time Net Worth
$4.163B
Estimated based on Medical devices stock value as of March 6, 2026
-1.02% (24h)
Age
79
Source
Medical devices
Industry
Healthcare
Citizenship
SWITZERLAND

Biography

Willy Michel is a Swiss entrepreneur and art collector, best known for founding Ypsomed, a leading medical device company. His net worth is estimated at $4.4 billion, stemming from his success in the healthcare industry. Michel's career began with the founding of Disetronic Holding AG in 1984, which developed advanced insulin pumps. He later sold Disetronic's infusion business to Roche and reacquired the injection business to establish Ypsomed in 2003. Through Ypsomed, he has contributed significantly to advancements in diabetes management and patient care, consistently pushing the boundaries of medical technology.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Wilhelm "Willy" Michel was born on April 29, 1947, in Switzerland. He developed a strong work ethic and a passion for entrepreneurship during his early years.

Rise to Success

In 1984, Willy Michel and his brother founded Disetronic Holding AG, focusing on medical infusion systems and developing advanced insulin pumps. By 2000, Disetronic had grown to over 1,021 employees and generated sales exceeding US$200 million. In 2003, he sold Disetronic's infusion business to Roche and reacquired the injection business, founding Ypsomed. Ypsomed has since become a global leader in self-injection systems and infusion pumps, operating in over 80 countries. His entrepreneurial ventures and strategic decisions, including the formation of Ypsomed, propelled his rise to becoming a billionaire.

Key Business Strategies

Michel's key strategy involved identifying and capitalizing on opportunities within the medical device market. He focused on innovation, particularly in insulin delivery systems, and expanded the company's reach globally. His success is also attributed to his 71% ownership of Ypsomed, which has given him significant control over its operations.

Philanthropy

Willy Michel is known for his philanthropic efforts and commitment to social responsibility. He has made significant donations to various charitable organizations and educational institutions.

Career Milestones

1984

Founded Disetronic Holding AG

Co-founded the company with his brother, focusing on medical infusion systems and insulin pumps.

2003

Founded Ypsomed

Reacquired the injection business from Roche, forming Ypsomed.

2005

Master Entrepreneur Award

Received the Master Entrepreneur award from Ernst & Young Switzerland.

Philanthropy & Social Impact

General Philanthropy

Various Charitable Donations

Undisclosed

Significant donations to various charitable organizations and educational institutions.